Title
Oral Nipah Vaccine
CoPED ID
8090d179-ff1d-45c7-beea-e72c38ecf93c
Status
Closed
Value
£1,443,040
Start Date
March 31, 2022
End Date
Sept. 30, 2023
Description
IosBio has developed a technology which enables the generation of thermally stable, orally administered vaccines. We will utilise this technology to develop a candidate Nipah vaccine, a disease identified as having pandemic potential.
| IOSBIO LTD | LEAD_ORG |
| IOSBIO LTD | PARTICIPANT_ORG |
| Andrew BACON | PM_PER |
Subjects by relevance
- Vaccines
- Pandemics
- Technology
- Technological development
- Development (active)
- Vaccination
- Communicable diseases
Extracted key phrases
- Candidate Nipah vaccine
- Oral Nipah Vaccine
- Technology
- Generation
- IosBio
- Stable
- Disease
- Pandemic potential